Hunan Jiudian Pharmaceutical Co (SZSE:300705) ROCE % : 27.99% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Hunan Jiudian Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hunan Jiudian Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 27.99%.

Hunan Jiudian Pharmaceutical Co ROCE % Historical Data

The historical data trend for Hunan Jiudian Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jiudian Pharmaceutical Co ROCE % Chart

Hunan Jiudian Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

7.67

10.55

20.84

19.11

19.17

Hunan Jiudian Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															24.88	6.91	23.87	26.65	27.99

Hunan Jiudian Pharmaceutical Co ROCE % Calculation

Hunan Jiudian Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	413.223	/	( ( (2299.71 - 444.345)	+	(2871.2 - 415.562) )	/ 2 )
	=	413.223	/	( (1855.365	+	2455.638)	/ 2 )
	=	413.223	/	2155.5015
	=	19.17 %

Hunan Jiudian Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	776.84	/	( ( (3067.507 - 379.448)	+	(3240.676 - 377.733) )	/ 2 )
	=	776.84	/	( ( 2688.059	+	2862.943 )	/ 2 )
	=	776.84	/	2775.501
	=	27.99 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hunan Jiudian Pharmaceutical Co (SZSE:300705) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hunan Jiudian Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hunan Jiudian Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jiudian Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No.1 Health Avenue, Hunan Liuyang Bio Pharmaceutical Park, Hunan, Changsha, CHN, 410329

Website

http://www.jiudianph.com

Hunan Jiudian Pharmaceutical Co Ltd is a China-based pharmaceutical company specializing in research and development, manufacturing of pharmaceutical products, solid and liquid oral preparations and herbal extract products. It manufactures dirithromycin, levodropropizine and levocetirizine hydrochloride in China. The group's products include active pharmaceutical ingredients, herbal extracts, intermediaries, excipients and finished products.

Executives

Zhu Zhi Hong	Director
Duan Bin	Supervisors
Liang Sheng Hua	Supervisors
Zheng Xia Hui	Directors, executives
Duan Li Xin	Director
Zhu Zhi Yun	Director
Xiong Ying	Executives
Li Min	Secretary Dong
Fan Peng Yun	Executives

Hunan Jiudian Pharmaceutical Co Headlines

No Headlines